Financial statements Bio Investment
Balance sheet data of BIO INVESTMENT
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 1 479 056,59 | 1 525 820,60 | 1 380 350,28 |
| A. Fixed assets | 787 371,78 | 751 465,78 | 707 617,00 |
| B. Current assets | 691 684,81 | 774 354,82 | 672 733,28 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 479 056,59 | 1 525 820,60 | 1 380 350,28 |
| A. Equity | 1 274 866,71 | 1 341 811,02 | 932 350,35 |
| B. Liabilities and provisions for liabilities | 204 189,88 | 184 009,58 | 447 999,93 |
| I. Long-term liabilities | 51 500,00 | 32 500,00 | 22 500,00 |
| II. Short-term liabilities | 152 689,88 | 151 509,58 | 425 499,93 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.